NEUROCRINE BIOSCIENCES INC
NBIX
59 insider filings · Latest: Aug 4, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2025 | Nov 5 9:19 PM | WILLIAM H. RASTETTER | Proposed Sale | 18,000 | $143.19 | $2.6M | — | View → |
| Aug 7, 2025 | Aug 7 8:24 PM | KEVIN CHARLES GORMAN | Proposed Sale | 106,322 | $128.43 | $13.7M | — | View → |
| Jul 10, 2025 | Jul 10 8:32 PM | INGRID DELAET | Proposed Sale | 457 | $133.51 | $61.0K | — | View → |
| Jul 2, 2025 | Jul 2 8:22 PM | JUDE ONYIA | Proposed Sale | 80,181 | $128.00 | $10.3M | — | View → |
| May 27, 2025 | May 27 8:38 PM | KEVIN CHARLES GORMAN | Proposed Sale | 9,613 | $120.18 | $1.2M | — | View → |
| May 5, 2025 | May 5 8:40 PM | WILLIAM H. RASTETTER | Proposed Sale | 30,000 | $109.68 | $3.3M | — | View → |
| Feb 14, 2025 | Feb 14 9:12 PM | EIRY WYN ROBERTS | Proposed Sale | 500 | $115.04 | $57.5K | — | View → |
| Feb 13, 2025 | Feb 13 9:38 PM | STEPHEN A SHERWIN | Proposed Sale | 13,831 | $117.18 | $1.6M | — | View → |
| Feb 13, 2025 | Feb 13 9:38 PM | MATTHEW ABERNETHY | Proposed Sale | 1,352 | $117.18 | $158.4K | — | View → |
| Feb 13, 2025 | Feb 13 9:37 PM | MATTHEW C ABERNETHY | Proposed Sale | 1,206 | $117.18 | $141.3K | — | View → |
| Feb 13, 2025 | Feb 13 9:37 PM | KEVIN CHARLES GORMAN | Proposed Sale | 3,012 | $117.18 | $352.9K | — | View → |
| Feb 13, 2025 | Feb 13 9:37 PM | KYLE W GANO | Proposed Sale | 1,206 | $117.18 | $141.3K | — | View → |
| Feb 13, 2025 | Feb 13 9:37 PM | JULIE SMITH COOKE | Proposed Sale | 755 | $117.18 | $88.5K | — | View → |
| Feb 13, 2025 | Feb 13 9:36 PM | ERIC S BENEVICH | Proposed Sale | 1,056 | $117.18 | $123.7K | — | View → |
| Feb 13, 2025 | Feb 13 9:36 PM | JUDE ONYIA | Proposed Sale | 1,447 | $117.18 | $169.6K | — | View → |
| Feb 13, 2025 | Feb 13 9:36 PM | INGRID DELAET | Proposed Sale | 755 | $117.18 | $88.5K | — | View → |
| Feb 13, 2025 | Feb 13 9:35 PM | DAVID WARREN BOYER | Proposed Sale | 830 | $117.18 | $97.3K | — | View → |
| Feb 13, 2025 | Feb 13 9:35 PM | DARIN LIPPOLDT | Proposed Sale | 1,086 | $117.18 | $127.3K | — | View → |
| Feb 13, 2025 | Feb 13 9:35 PM | EIRY WYN ROBERTS | Proposed Sale | 604 | $117.18 | $70.8K | — | View → |
| Feb 13, 2025 | Feb 13 9:34 PM | EIRY ROBERTS | Proposed Sale | 1,114 | $117.18 | $130.5K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Feb 17 10:44 PM | Sanjay Chandru KeswaniChief Medical Officer | Grant/Award | 42,112 | $124.12 | 6,285(D) | View → |
| Jan 31, 2026 | Feb 3 11:22 PM | David W. BoyerChief Corp. Affairs Officer | Option Exercise | 2,096 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:21 PM | Eric BenevichChief Commercial Officer | Option Exercise | 2,294 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:06 PM | Matt AbernethyChief Financial Officer | Option Exercise | 2,437 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:05 PM | Julie CookeChief Human Resources Officer | Option Exercise | 1,741 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:04 PM | Ingrid DelaetChief Regulatory Officer | Option Exercise | 801 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:03 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 2,927 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:02 PM | Kevin Charles GormanDirector | Option Exercise | 5,142 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:01 PM | Darin LippoldtChief Legal Officer | Option Exercise | 2,373 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:01 PM | Jude OnyiaChief Scientific Officer | Option Exercise | 238 | — | 0(D) | View → |
| Jan 16, 2026 | Jan 20 11:56 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 36,400 | $35.99 | 0(D) | View → |
← Previous
Page 4 of 4